Literature DB >> 34246006

A 6-month study on the pattern of emergency department presentations for schizophrenia and other psychotic disorders during COVID-19 lockdown.

Karuppiah Jagadheesan1, Vijay Danivas2, Quratulain Itrat2, Lokesh Shekaran2, Vinay Lakra3.   

Abstract

This study investigated the characteristics of patients with schizophrenia and other psychotic disorders presenting to emergency departments (ED) for psychiatric treatment during the first six months of the COVID-19 lockdown in Melbourne. This cross-sectional data-base study included adult patients in the North West Area Mental Health Service's catchment area who had visited two emergency departments (EDs) during the study period (March 16-September 16, 2020) and the control period (March 16-September 16, 2019). Compared to the control period (n = 467), the lockdown period (n = 451) had a 6.8% more psychotic disorders. This increase was particularly noted for schizophrenia and acute transient psychosis. In a sub-analysis of psychotic disorder group alone, compared to the control period, more patients were discharged to the community in the lockdown period. In another sub-analysis, compared to the mood disorder group, psychotic disorder group included more patients in 26-35 and 46-55 age groups, men, emergency triage category, and hospital admissions and higher mean duration of ED stay in the lockdown period. Overall, patients with psychotic disorders had increased ED presentations and appeared to be in an emergency state when they present to ED during the lockdown.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  COVID-19; Emergency department; Lockdown; Psychosis; Schizophrenia

Year:  2021        PMID: 34246006     DOI: 10.1016/j.psychres.2021.114081

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Perceived empowerment and the impact of negative effects of the COVID-19 pandemic on the quality of life of persons with severe mental illness.

Authors:  Annabel Sandra Mueller-Stierlin; Friedrich Meixner; Jutta Lehle; Anne Kohlmann; Mara Schumacher; Stefanie Woehler; Anke Haensel; Sabrina Reuter; Katrin Herder; Nicole Bias; Thomas Becker; Reinhold Kilian
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

2.  Changes in Psychiatric Inpatient Service Utilization During the First and Second Waves of the COVID-19 Pandemic.

Authors:  Matilda Hamlin; Thérèse Ymerson; Hanne Krage Carlsen; Marzia Dellepiane; Örjan Falk; Michael Ioannou; Steinn Steingrimsson
Journal:  Front Psychiatry       Date:  2022-02-17       Impact factor: 4.157

3.  Risk of First-Episode Schizophrenia in Aged Adults Increased During COVID-19 Outbreak.

Authors:  Wei Hu; Li Su; Deyong Li; Yi Zhou; Jing Zhu
Journal:  Int J Ment Health Addict       Date:  2021-10-12       Impact factor: 11.555

4.  Real-world performance of Victorian hospitals during the COVID-19 lockdowns.

Authors:  Stephen Allison; Tarun Bastiampillai; Jeffrey Cl Looi; David Copolov; Vinay Lakra
Journal:  Australas Psychiatry       Date:  2022-04       Impact factor: 1.369

5.  Suicidality in psychiatric emergency department situations during the first and the second wave of COVID-19 pandemic.

Authors:  Yann David Kippe; Maia Adam; Anna Finck; James Kenneth Moran; Meryam Schouler-Ocak; Felix Bermpohl; Stefan Gutwinski; Thomas Goldschmidt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-07       Impact factor: 5.760

6.  Mid-term psychiatric consequences of the COVID-19 pandemic: a 4 months observational study on emergency room admissions for psychiatric evaluation after the (first) lockdown period in Italy.

Authors:  Massimiliano Beghi; Silvia Ferrari; Laura Biondi; Riccardo Brandolini; Claudia Corsini; Giovanni De Paoli; Rosa Patrizia Sant'Angelo; Carlo Fraticelli; Ilaria Casolaro; Mikhail Zinchuk; Evgenii Pashnin; Lina Urh; Giulio Castelpietra; Cesare Maria Cornaggia
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-03-13       Impact factor: 4.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.